Arteriovenous malformations (AVMs) in the pediatric population are relatively rare but reportedly carry a higher rate of rupture than in adults. This could be due to the fact that most pediatric AVMs are only detected after rupture. We aimed to review the current literature regarding the natural history and the clinical outcome after multimodality AVM treatment in the pediatric population, as optimal management for pediatric AVMs remains controversial. A multidisciplinary approach using multimodality therapy if needed has been proved to be beneficial in approaching these lesions in all age groups. Microsurgical resection remains the gold standard for the treatment of all accessible pediatric AVMs. Embolization and radiosurgery should be considered as an adjunctive therapy. Embolization provides a useful adjunct therapy to microsurgery by preventing significant blood loss and to radiosurgery by decreasing the volume of the AVM. Radiosurgery has been described to provide an alternative treatment approach in certain circumstances either as a primary or adjuvant therapy.

Keywords:
Stereotactic radiosurgery, Arteriovenous malformations, Pediatrics, Endovascular embolization, Microsurgery
1.
Hofmeister C, et al: Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke 2000;31:1307-1310.
2.
Smyth MD, et al: Stereotactic radiosurgery for pediatric intracranial arteriovenous malformations: the University of California at San Francisco experience. J Neurosurg 2002;97:48-55.
3.
Celli P, et al: Cerebral arteriovenous malformations in children. Clinical features and outcome of treatment in children and in adults. Surg Neurol 1984;22:43-49.
4.
Humphreys RP: Complications of hemorrhagic stroke in children. Pediatr Neurosurg 1991;17:163-168.
5.
Di Rocco C, Tamburrini G, Rollo M: Cerebral arteriovenous malformations in children. Acta Neurochir (Wien) 2000;142:145-156; discussion 156-158.
6.
Humphreys RP, et al: Choices in the 1990s for the management of pediatric cerebral arteriovenous malformations. Pediatr Neurosurg 1996;25:277-285.
7.
Millar C, Bissonnette B, Humphreys RP: Cerebral arteriovenous malformations in children. Can J Anaesth 1994;41:321-331.
8.
Kiris T, et al: Surgical results in pediatric Spetzler-Martin grades I-III intracranial arteriovenous malformations. Childs Nerv Syst 2005;21:69-74; discussion 75-76.
9.
Hoh BL, et al: Multimodality treatment of nongalenic arteriovenous malformations in pediatric patients. Neurosurgery 2000;47:346-357; discussion 357-358.
10.
Kondziolka D, et al: Arteriovenous malformations of the brain in children: a forty year experience. Can J Neurol Sci 1992;19:40-45.
11.
Wilkins RH: Natural history of intracranial vascular malformations: a review. Neurosurgery 1985;16:421-430.
12.
Jankowitz BT, et al: Treatment of pediatric intracranial vascular malformations using Onyx-18. J Neurosurg Pediatr 2008;2:171-176.
13.
Gaballah M, et al: Intraoperative cerebral angiography in arteriovenous malformation resection in children: a single institutional experience. J Neurosurg Pediatr 2014;13:222-228.
14.
Blamek S, Larysz D, Miszczyk L: Stereotactic linac radiosurgery and hypofractionated stereotactic radiotherapy for pediatric arteriovenous malformations of the brain: experiences of a single institution. Childs Nerv Syst 2013;29:651-656.
15.
Karhunen PJ, Penttila A, Erkinjuntti T: Arteriovenous malformation of the brain: imaging by postmortem angiography. Forensic Sci Int 1990;48:9-19.
16.
Matson DD, Ingraham FD: Neurosurgery of Infancy and Childhood, ed 2. Springfield, IL, Thomas, 1969, p 934.
17.
Sanchez-Mejia RO, et al: Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg 2006;105(2 suppl):82-87.
18.
Soltanolkotabi M, et al: Onyx embolization of intracranial arteriovenous malformations in pediatric patients. J Neurosurg Pediatr 2013;11:431-437.
19.
Zheng T, et al: Clinical features and endovascular treatment of intracranial arteriovenous malformations in pediatric patients. Childs Nerv Syst 2014;30:647-653.
20.
Nair AP, et al: Clinical, radiological profile and outcome in pediatric Spetzler-Martin grades I-III arteriovenous malformations. Childs Nerv Syst 2012;28:593-598.
21.
Darsaut TE, et al: Management of pediatric intracranial arteriovenous malformations: experience with multimodality therapy. Neurosurgery 2011;69:540-556; discussion 556.
22.
Han PP, Ponce FA, Spetzler RF: Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg 2003;98:3-7.
23.
Jayaraman MV, et al: Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: is treatment justified? Stroke 2007;38:325-329.
24.
Hernesniemi JA, et al: Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 2008;63:823-829; discussion 829-831.
25.
Stapf C, et al: Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006;66:1350-1355.
26.
Gerszten PC, et al: Seizure outcome in children treated for arteriovenous malformations using gamma knife radiosurgery. Pediatr Neurosurg 1996;24:139-144.
27.
Spetzler RF, et al: Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg 1992;76:918-923.
28.
Waltimo O: The relationship of size, density and localization of intracranial arteriovenous malformations to the type of initial symptom. J Neurol Sci 1973;19:13-19.
29.
Langer DJ, et al: Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery 1998;42:481-486; discussion 487-489.
30.
Arnaout OM, et al: Posterior fossa arteriovenous malformations. Neurosurg Focus 2009;26:E12.
31.
Khaw AV, et al: Association of infratentorial brain arteriovenous malformations with hemorrhage at initial presentation. Stroke 2004;35:660-663.
32.
Meisel HJ, et al: Cerebral arteriovenous malformations and associated aneurysms: analysis of 305 cases from a series of 662 patients. Neurosurgery 2000;46:793-800; discussion 800-802.
33.
Stefani MA, et al: Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 2002;33:1220-1224.
34.
Redekop G, et al: Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg 1998;89:539-546.
35.
Altschuler EM, et al: Gamma knife radiosurgery for intracranial arteriovenous malformations in childhood and adolescence. Pediatr Neurosci 1989;15:53-61.
36.
Griffiths PD, Beveridge CJ, Gholkar A: Angiography in non-traumatic brain haematoma. An analysis of 100 cases. Acta Radiol 1997;38:797-802.
37.
Yamamoto M, et al: Long-term follow-up results of intentional 2-stage gamma knife surgery with an interval of at least 3 years for arteriovenous malformations larger than 10 cm3. J Neurosurg 2012;117(suppl):126-134.
38.
Willinsky RA, et al: Delayed angiography in the investigation of intracerebral hematomas caused by small arteriovenous malformations. Neuroradiology 1993;35:307-311.
39.
Miyamoto S, et al: Posttreatment sequelae of palliatively treated cerebral arteriovenous malformations. Neurosurgery 2000;46:589-594; discussion 594-595.
40.
Guo WY, et al: Even the smallest remnant of an AVM constitutes a risk of further bleeding. Case report. Acta Neurochir (Wien) 1993;121:212-215.
41.
Kano H, et al: Stereotactic radiosurgery for arteriovenous malformations, part 2: management of pediatric patients. J Neurosurg Pediatr 2012;9:1-10.
42.
Yen CP, et al: Gamma knife surgery for arteriovenous malformations in children. J Neurosurg Pediatr 2010;6:426-434.
43.
So SC: Cerebral arteriovenous malformations in children. Childs Brain 1978;4:242-250.
44.
Blount JP, et al: History of surgery for cerebrovascular disease in children. Part III. Arteriovenous malformations. Neurosurg Focus 2006;20:E11.
45.
Nicolato A, et al: Gamma knife radiosurgery for cerebral arteriovenous malformations in children/adolescents and adults. Part I: differences in epidemiologic, morphologic, and clinical characteristics, permanent complications, and bleeding in the latency period. Int J Radiat Oncol Biol Phys 2006;64:904-913.
46.
Schaller C, Schramm J: Microsurgical results for small arteriovenous malformations accessible for radiosurgical or embolization treatment. Neurosurgery 1997;40:664-672; discussion 672-674.
47.
Heros RC, Korosue K, Diebold PM: Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery 1990;26:570-577; discussion 577-578.
48.
Hamilton MG, Spetzler RF: The prospective application of a grading system for arteriovenous malformations. Neurosurgery 1994;34:2-6; discussion 6-7.
49.
Riva D, et al: Radiosurgery for cerebral AVMs in children and adolescents: the neurobehavioral outcome. J Neurosurg 1997;86:207-210.
50.
Frizzel RT, Fisher WS 3rd: Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1,246 patients in 32 series over a 35-year period. Neurosurgery 1995;37:1031-1039; discussion 1039-1040.
51.
Kondziolka D, et al: Radiosurgical management of pediatric arteriovenous malformations. Childs Nerv Syst 2010;26:1359-1366.
52.
Bristol RE, et al: Surgical management of arteriovenous malformations in children. J Neurosurg 2006;105(2 suppl):88-93.
53.
Berenstein A, et al: Endovascular management of arteriovenous malformations and other intracranial arteriovenous shunts in neonates, infants, and children. Childs Nerv Syst 2010;26:1345-1358.
54.
Herman TE, et al: Cerebral arteriovenous fistula to pulmonary artery Onyx embolization. J Perinatol 2007;27:238-240.
55.
Murugesan C, et al: Severe pulmonary oedema following therapeutic embolization with Onyx for cerebral arteriovenous malformation. Neuroradiology 2008;50:439-442.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.